SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-065923
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:37
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111682d1_10q.htm 10-Q 425764
2 EXHIBIT 31.1 tm2111682d1_ex31-1.htm EX-31.1 8937
3 EXHIBIT 32.1 tm2111682d1_ex32-1.htm EX-32.1 4310
4 EXHIBIT 31.2 tm2111682d1_ex31-2.htm EX-31.2 8911
  Complete submission text file 0001104659-21-065923.txt   4167735

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20210331.xml EX-101.INS 988364
6 XBRL TAXONOMY EXTENSION SCHEMA catb-20210331.xsd EX-101.SCH 41737
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE catb-20210331_cal.xml EX-101.CAL 39416
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE catb-20210331_def.xml EX-101.DEF 149715
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE catb-20210331_lab.xml EX-101.LAB 367972
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE catb-20210331_pre.xml EX-101.PRE 276352
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 21919609
SIC: 2834 Pharmaceutical Preparations